In Bill Gates' latest move in the market for initial public offerings, the billionaire has taken a nine percent stake in Corus Pharma's IPO, through his Cascade Investment LLC firm. The Microsoft chairman purchased 3.55 million shares of the Seattle drug development firm at a price of 97 cents per share on Feb. 21, 2003, according to Corus Pharma's $100 million IPO, filed Friday.
|